Blepharitis (1)

Completed (1)

phase 2/phase 3 (1)

Tarsus Pharmaceuticals, Inc. (1)

tp-03 vehicle (1)

tp-03, 0.25% (1)

drug (1)

Industry (1)

Interventional (1)

Blepharitis

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Jul 7, 2022